SD Biosensor, Inc. (137310) Price & Analysis

― Followers

137310 Stock Chart & Stats

$6350.00

$180.00(2.92%)

Jul 31, 2026

―

Day’s Range― - ―

52-Week Range$5,800.00 - $10,930.00

Previous CloseN/A

VolumeN/A

Average Volume (3M)N/A

Market Cap

₩753.23B

Enterprise Value$769.94K

Total Cash (Recent Filing)₩461.03B

Total Debt (Recent Filing)₩309.61B

Price to Earnings (P/E)―

Beta0.15

Next Earnings

Aug 07, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-3900.30

Shares Outstanding120,749,100

10 Day Avg. VolumeN/A

30 Day Avg. VolumeN/A

Financial Highlights & Ratios

PEG Ratio>-0.01

Price to Book (P/B)0.47

Price to Sales (P/S)1.52

P/FCF Ratio3.61

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

137310 FAQ

What was SD Biosensor, Inc.’s price range in the past 12 months?

SD Biosensor, Inc. lowest stock price was $5800.00 and its highest was $10930.00 in the past 12 months.

What is SD Biosensor, Inc.’s market cap?

SD Biosensor, Inc.’s market cap is ₩753.23B.

When is SD Biosensor, Inc.’s upcoming earnings report date?

SD Biosensor, Inc.’s upcoming earnings report date is Aug 07, 2026 which is in 5 days.

How were SD Biosensor, Inc.’s earnings last quarter?

SD Biosensor, Inc. released its earnings results on May 14, 2026. The company reported $189.809 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.

Is SD Biosensor, Inc. overvalued?

According to Wall Street analysts SD Biosensor, Inc.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does SD Biosensor, Inc. pay dividends?

SD Biosensor, Inc. does not currently pay dividends.

What is SD Biosensor, Inc.’s EPS estimate?

SD Biosensor, Inc.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does SD Biosensor, Inc. have?

SD Biosensor, Inc. has 120,749,100 shares outstanding.

What happened to SD Biosensor, Inc.’s price movement after its last earnings report?

SD Biosensor, Inc. reported an EPS of $189.809 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 8.087%.

Which hedge fund is a major shareholder of SD Biosensor, Inc.?

Currently, no hedge funds are holding shares in KR:137310

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

SD Biosensor, Inc.

SD BioSensor Inc., a global leader in in-vitro diagnostics, delivers advanced point-of-care testing solutions from its base in South Korea. The company's diverse product portfolio features the STANDARD Q rapid diagnostic platform, offering quick results for various parameters including COVID-19. For laboratory settings, they provide the STANDARD F, a multi-parametric, random-access fluorescence immunoassay system, and the STANDARD E, an ELISA-based solution ideal for extensive screening programs. Their STANDARD M system brings molecular diagnostics closer to the patient, comprising analyzers, assay menus, qPCR reagents, and nucleic acid extraction kits. Furthermore, the procell Dx range focuses on diagnosing infectious diseases such as tuberculosis and SARS-CoV-2, alongside assessing immune status through interferon-gamma release assays. Blood glucose meters also form part of their offerings. Founded in 2010, SD BioSensor is headquartered in Suwon.